CABT-BL615

antibody from Creative Diagnostics
Targeting: URI1 C19orf2, FLJ10575, NNX3, PPP1R19, RMP, URI
Provider product page for CABT-BL615
Western blot
ELISA

Antibody data

Product number
CABT-BL615 - Provider product page
Provider
Creative Diagnostics
Product name
Anti-C19ORF2 (C-terminal) polyclonal antibody
Antibody type
Polyclonal
Description
Involved in gene transcription regulation. Acts as a transcriptional repressor in concert with the corepressor UXT to regulate androgen receptor (AR) transcription. May act as a tumor suppressor to repress AR-mediated gene transcription and to inhibit anchorage-independent growth in prostate cancer cells. Required for cell survival in ovarian cancer cells. Together with UXT, associates with chromatin to the NKX3-1 promoter region. Antagonizes transcriptional modulation via hepatitis B virus X protein.Plays a central role in maintaining S6K1 signaling and BAD phosphorylation under normal growth conditions thereby protecting cells from potential deleterious effects of sustained S6K1 signaling. The URI1-PPP1CC complex acts as a central component of a negative feedback mechanism that counteracts excessive S6K1 survival sigaling to BAD in response to growth factors. Mediates inhibition of PPP1CC phosphatase activity at mitochondria. Coordinates the regulation of nutrient-sensitive gene expression availability in a mTOR-dependent manner. Seems to be a scaffolding protein able to assemble a prefoldin-like complex that contains PFDs and proteins with roles in transcription and ubiquitination.
Reactivity
Human
Host
Rabbit
Conjugate
Unconjugated
Isotype
IgG
Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
URI1 protein structure - CABT-BL615 shown in red.